Hugh M. Davis

Chief Operating Officer, Aclaris Therapeutics, Inc.

Companies

Aclaris Therapeutics, Inc.Board member Nov 18, 2024 to now¹
Aclaris Therapeutics, Inc.Chief operating officer Nov 18, 2024 to now¹
Aclaris Therapeutics, Inc.President Nov 18, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aclaris Therapeutics, Inc. ACRS45,425 shares²$153.5K at $3.38Feb 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 3, 2026Exercised options 18,675 shares of Aclaris Therapeutics, Inc.²
Dec 2, 2025Exercised options 26,750 shares of Aclaris Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAclaris Therapeutics, Inc., Board member
2
SEC EDGARAclaris Therapeutics, Inc. shares after the filing of Feb 3, 2026
3
SEC EDGARForm 4 filed Dec 4, 2025